This inventor holds 3 USPTO granted patents. Top assignee: Northwestern University. Active years: 2019-2023.
Company Filing History:
Years Active: 2019-2023
Title: Lu Wang - Innovator in Cancer Therapeutics
Introduction
Lu Wang is a prominent inventor based in Chicago, IL (US). He has made significant contributions to the field of cancer research, particularly through his innovative approaches to therapeutic targeting. With a total of 3 patents, his work focuses on developing methods and compounds that aim to improve cancer treatment outcomes.
Latest Patents
One of Lu Wang's latest patents is titled "Therapeutic targeting of the BAP1 complex in cancer." This patent discloses methods, compounds, and compositions for treating cancers characterized by therapeutic targeting of the BAP1 histone H2A deubiquitinase (DUB) complex. The methods and compounds aim to inhibit the biological activity of the BAP1 complex, specifically for treating cancers such as myeloid neoplasms. Another significant patent is "Therapeutic targeting of SET1B/COMPASS pathway for treating cancers." This patent outlines methods for treating Set1/COMPASS-associated cancers characterized by the expression of Set1B/COMPASS. The methods typically involve administering a therapeutic amount of an inhibitor of the Set1B/COMPASS pathway and/or an agonist for a target that is negatively regulated by this pathway.
Career Highlights
Lu Wang is affiliated with Northwestern University, where he conducts his research and development work. His innovative contributions to cancer therapeutics have positioned him as a key figure in the scientific community. His dedication to advancing cancer treatment through targeted therapies is evident in his research endeavors.
Collaborations
Lu Wang collaborates with Ali Shilatifard, a fellow researcher who brings valuable expertise to their joint efforts in cancer research. Their partnership enhances the potential for groundbreaking discoveries in the field.
Conclusion
Lu Wang's work exemplifies the impact of innovation in cancer therapeutics. His patents and research efforts contribute significantly to the ongoing fight against cancer, showcasing the importance of targeted treatment strategies.